| Summary: | The invasion of pathogenic fungi poses nonnegligible threats to the human health and agricultural industry. This work exploited a family of hydroxyethyl naphthalimides as novel antifungal species with synergistic potential of chemical and dynamic treatment to combat the fungal resistance. These prepared naphthalimides showed better antifungal potency than fluconazole towards some tested fungi including <i>Aspergillus fumigatus</i>, <i>Candida tropicalis</i> and <i>Candida parapsilosis</i> 22019. Especially, thioether benzimidazole derivative <b>7f</b> with excellent anti-<i>Candida tropicalis</i> efficacy (MIC = 4 μg/mL) possessed low cytotoxicity, safe hemolysis level and less susceptibility to induce resistance. Biochemical interactions displayed that <b>7f</b> could form a supramolecular complex with DNA to block DNA replication, and constitute a biosupermolecule with cytochrome P450 reductase (CPR) from <i>Candida tropicalis</i> to hinder CPR biological function. Additionally, <b>7f</b> presented strong lipase affinity, which facilitated its permeation into cell membrane. Moreover, <b>7f</b> with dynamic antifungal potency promoted the production and accumulation of reactive oxygen species (ROS) in cells, which destroyed the antioxidant defence system, led to oxidative stress with lipid peroxidation, loss of glutathione, membrane dysfunction and metabolic inactivation, and eventually caused cell death. The chemical and dynamic antifungal synergistic effect initiated by hydroxyethyl naphthalimides was a reasonable treatment window for prospective development.
|
|---|